Literature DB >> 29086381

Unindicated multiphase CT scans in non-traumatic abdominal emergencies for women of reproductive age: a significant source of unnecessary exposure.

Caterina Giannitto1, Mauro Campoleoni2, Sara Maccagnoni3, Alessio Salvatore Angileri3, Maria Carmela Grimaldi3, Nino Giannitto4, Francesca De Piano3, Eleonora Ancona3, Pietro Raimondo Biondetti5, Andrea Alessandro Esposito5.   

Abstract

PURPOSE: To determine the frequency of unindicated CT phases and the resultant excess of absorbed radiation doses to the uterus and ovaries in women of reproductive age who have undergone CT for non-traumatic abdomino-pelvic emergencies.
MATERIALS AND METHODS: We reviewed all abdomino-pelvic CT examinations in women of reproductive age (40 years or less), between 1 June 2012 and 31 January 2015. We evaluated the appropriateness of each CT phase on the basis of clinical indications, according to ACR appropriateness criteria and evidence-based data from the literature. The doses to uterus and ovaries for each phase were calculated with the CTEXPO software, taking into consideration the size-specific dose estimate (SSDE) after measuring the size of every single patient.
RESULTS: The final cohort was composed of 76 female patients with an average age of 30 (from 19 to 40 years). In total, 197 CT phases were performed with an average of 2.6 phases per patient. Out of these, 93 (47%) were unindicated with an average of 1.2 inappropriate phases per patient. Unindicated scans were most frequent for appendicitis and unlocalized abdominal pain. The excesses of mean radiation doses to the uterus and ovaries due to unindicated phases were, respectively, of 38 and 33 mSv per patient.
CONCLUSION: In our experience, unindicated additional CT phases were numerous with a significant excess radiation dose without an associated clinical benefit. This excess of radiation could have been avoided by widespread adoption of the ACR appropriateness criteria and evidence-based data from the literature.

Entities:  

Keywords:  Computed tomography; Emergency; Radiation protection; Women

Mesh:

Year:  2017        PMID: 29086381     DOI: 10.1007/s11547-017-0819-6

Source DB:  PubMed          Journal:  Radiol Med        ISSN: 0033-8362            Impact factor:   3.469


  6 in total

1.  Overuse of computed tomography for minor head injury in young patients: an analysis of promoting factors.

Authors:  Michaela Cellina; Marta Panzeri; Chiara Floridi; Carlo Maria Andrea Martinenghi; Giulio Clesceri; Giancarlo Oliva
Journal:  Radiol Med       Date:  2018-03-07       Impact factor: 3.469

2.  Multicentric study of patients receiving 50 or 100 mSv in a single day through CT imaging-frequency determination and imaging protocols involved.

Authors:  Madan M Rehani; John Heil; Vinit Baliyan
Journal:  Eur Radiol       Date:  2021-03-08       Impact factor: 5.315

3.  Patients undergoing recurrent CT exams: assessment of patients with non-malignant diseases, reasons for imaging and imaging appropriateness.

Authors:  Madan M Rehani; Emily R Melick; Raza M Alvi; Ruhani Doda Khera; Salma Batool-Anwar; Tomas G Neilan; Michael Bettmann
Journal:  Eur Radiol       Date:  2019-12-02       Impact factor: 5.315

4.  The role of imaging in surgical planning for liver resection: what the radiologist need to know.

Authors:  Andrea Agostini; Alessandra Borgheresi; Chiara Floridi; Marina Carotti; Giulia Grazzini; Francesco Pagnini; Susanna Guerrini; Pierpaolo Palumbo; Silvia Pradella; Gianpaolo Carrafiello; Marco Vivarelli; Andrea Giovagnoni
Journal:  Acta Biomed       Date:  2020-07-13

5.  Feasibility Study of Dose Modulation for Reducing Radiation Dose with Arms-Down Patient Position in Abdominal Computed Tomography.

Authors:  Jina Shim; Yong Eun Chung; Hyun-Woo Jeong; Youngjin Lee
Journal:  Diagnostics (Basel)       Date:  2022-01-27

6.  Multiphase abdomen-pelvis CT in women of childbearing potential (WOCBP): Justification and radiation dose.

Authors:  Huda Al Naemi; Antar Aly; Mohamad Hassan Kharita; Shatha Al Hilli; Amal Al Obadli; Ramandeep Singh; Madan M Rehani; Mannudeep K Kalra
Journal:  Medicine (Baltimore)       Date:  2020-01       Impact factor: 1.817

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.